The eff ect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: A retrospective analysis

The Lancet

Volumn 380, Issue 9840, 2012, Pages 491-498

  O'Reilly, Kathleen M ^a   Durry, Elias ^b   Ul Islam, Obaid ^b   Quddus, Arshad ^c   Abid, Ni'ma ^b   Mir, Tahir P ^d   Tangermann, Rudi H ^e   Aylward, R Bruce ^e   Grassly, Nicholas C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WHO Country Office   (Pakistan)

^c WHO Country Office   (Afghanistan)

^d Polio Eradication Initiative   (Egypt)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ADOLESCENT; AFGHANISTAN; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FLACCID PARALYSIS; HEALTH PROGRAM; HUMAN; IMMUNITY; INFANT; MASS IMMUNIZATION; NEWBORN; PAKISTAN; POLIOMYELITIS; POLIOMYELITIS VIRUS 1; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; ACUTE DISEASE; CASE CONTROL STUDY; CLASSIFICATION; COMPARATIVE STUDY; ENDEMIC DISEASE; FEMALE; IMMUNOLOGY; INCIDENCE; MALE; METHODOLOGY; MUSCLE HYPOTONIA; ORGANIZATION AND MANAGEMENT; PARALYSIS; PATHOGENICITY; POLIOMYELITIS VIRUS; PREVENTIVE HEALTH SERVICE; STATISTICAL MODEL; STATISTICS; VIROLOGY; WORLD HEALTH ORGANIZATION;

ACUTE DISEASE; ADOLESCENT; AFGHANISTAN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MASS VACCINATION; MUSCLE HYPOTONIA; PAKISTAN; PARALYSIS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; WORLD HEALTH ORGANIZATION;

EID: 84864739350     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60648-5     Document Type: Article

References (25)

1. WHO. Polio case count. http://apps.who.int/immunization-monitoring/en/ diseases/poliomyelitis/case-count.cfm (accessed Feb 20, 2012).
2. Independent Monitoring Board of the Global Polio Eradication Initiative. Ten months and counting, February 2012. http://www.polioeradication.org/Portals/ 0/Document/Aboutus/Governance/IMB/5IMBMeeting/IMBReport-January2012.pdf (accessed April 6, 2012).
3. WHO. Outbreak news. Confirmed international spread of wild poliovirus from Pakistan. Wkly Epidemiol Rec 2011; 86: 437-38.
4. Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991; 13: 926-39.
5. Caceres VM, Sutter RW. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis 2001; 33: 531-41.
6. El-Sayed N, El-Gamal Y, Abbassy AA, et al. Monovalent type 1 oral poliovirus vaccine in newborns. N Engl J Med 2008; 359: 1655-65.
7. Grassly NC, Wenger J, Durrani S, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet 2007; 369: 1356-62.
8. Sutter RW, John TJ, Jain H, et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet 2010; 376: 1682-88.
9. Federal Ministry of Health, Government of Islamic Republic of Pakistan. National emergency action plan 2011 for polio eradication. http://www. polioeradication.org/Portals/0/Document/InfectedCountries/Pakistan/ PakistanStrategy/NationalEmergencyActionPlan.pdf (accessed Feb 20, 2012).
10. Abid N, Islam OU, Bosan A, Iqbal T, Darwish A, Bile KM. Pakistan's fight against poliomyelitis: introducing innovative strategies to address challenges and attain the goal of eradication. East Mediterr Health J 2010; 16 (suppl): S5-14.
11. Independent Monitoring Board of the Global Polio Eradication Initiative. Report, October 2011. http://www.polioeradication.org/Portals/0/Document/ Aboutus/Governance/IMB/4IMBMeeting/IMBReportOctober2011.pdf (accessed Feb 20, 2012).
12. Executive Board of WHO. Poliomyelitis: intensification of the global eradication initiative. http://apps.who.int/gb/ebwha/pdf-files/EB130/B130-R10- en.pdf (accessed Feb 20, 2012).
13. Mushtaq MU, Majrooh MA, Ullah MZ, et al. Are we doing enough? Evaluation of the Polio Eradication Initiative in a district of Pakistan's Punjab province: an LQAS study. BMC Public Health 2010; 10: 60.
14. WHO. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2007-June 2008. Wkly Epidemiol Rec 2008; 83: 321-28.
15. WHO. Progress towards poliomyelitis eradication, Pakistan, January 1999-June 2000. Wkly Epidemiol Rec 2000; 75: 274-77.
16. WHO. Progress towards poliomyelitis eradication. Afghanistan and Pakistan, January 2000-April 2002. Wkly Epidemiol Rec 2002; 77: 205-10.
17. WHO. Update on vaccine-derived polioviruses detected worldwide, July 2009-March 2011. Wkly Epidemiol Rec 2011; 86: 277-88.
18. Grassly NC, Jafari H, Bahl S, et al. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis 2009; 200: 794-801.
19. Grassly NC, Fraser C, Wenger J, et al. New strategies for the elimination of polio from India. Science 2006; 314: 1150-53.
20. Clayton D, Hills M. Statistical models in epidemiology. Oxford: Oxford University Press, 1993.
21. Hilborn R, Mangel M. The ecological detective; confronting models with data. New Jersey: Princeton University Press, 1997.
22. Posey DL, Linkins RW, Oliveria MJC, Monteiro D, Patriarca PA. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis 1997; 175: S258-63.
23. Barros AJD, Ronsmans C, Axelson H, et al. Equity in maternal, newborn, and child health interventions in Countdown to 2015: a retrospective review of survey data from 54 countries. Lancet 2012; 379: 1225-33.
24. Tangermann RH, Hull HF, Jafari H, Nkowane B, Everts H, Aylward RB. Eradication of poliomyelitis in countries affected by conflict. Bull World Health Organ 2000; 78: 330-38.
25. Closser S. Chasing polio in Pakistan. Why the world's largest public health initiative may fail. Nashville: Vanderbilt Univeristy Press, 2010.